Medicare Enrolled

Dr. Nicholas Dcunha, MD

Hematology & Oncology · Lubbock, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
602 INDIANA AVE, Lubbock, TX 79415
8067758600
In practice since 2005 (20 years)
NPI: 1104815802 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dcunha from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dcunha? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dcunha

Dr. Nicholas Dcunha is a hematology & oncology in Lubbock, TX, with 20 years in practice. Based on federal Medicare data, Dr. Dcunha performed 158 Medicare services across 124 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dcunha received a total of $26,468 from 46 pharmaceutical and/or device companies across 252 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dcunha is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ 158 Medicare services$ $26,468 industry payments

Medicare Practice Summary

Medicare Utilization ↗
158
Medicare services
Bottom 12% in TX for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
124
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~8 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)109$75$220
Office visit, established patient, complex (40-54 min)19$112$309
New patient office visit (45-59 min)17$104$285
Office visit, established patient (20-29 min)13$52$155
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$26,468
Total received (2018-2024)
Avg $3,781/year across 7 years
Top 18% in TX for hematology & oncology
46
Companies
252
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$11,124 (42.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$9,011 (34.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,333 (23.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,523
2023
$624
2022
$6,690
2021
$1,152
2020
$4,454
2019
$7,433
2018
$2,591

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Kite Pharma, Inc.
$5,457
Pharmacosmos Therapeutics Inc.
$5,372
Incyte Corporation
$3,790
Karyopharm Therapeutics Inc.
$2,325
Epizyme, Inc.,
$2,105
Astellas Pharma US Inc
$893
GENZYME CORPORATION
$568
Genentech USA, Inc.
$527
Amgen Inc.
$479
AstraZeneca Pharmaceuticals LP
$445
Daiichi Sankyo Inc.
$360
Alexion Pharmaceuticals, Inc.
$333
Novartis Pharmaceuticals Corporation
$260
Pharmacyclics LLC, An AbbVie Company
$238
Merck Sharp & Dohme Corporation
$237
E.R. Squibb & Sons, L.L.C.
$233
Takeda Pharmaceuticals U.S.A., Inc.
$219
Seattle Genetics, Inc.
$199
JAZZ PHARMACEUTICALS INC.
$198
Janssen Scientific Affairs, LLC
$198
Seagen Inc.
$176
Exelixis Inc.
$141
Celgene Corporation
$138
Eisai Inc.
$130
Apellis Pharmaceuticals, Inc.
$125
ABBVIE INC.
$121
Novocure Inc.
$112
TerSera Therapeutics LLC
$108
Janssen Pharmaceuticals, Inc
$108
PFIZER INC.
$100
Pharmacyclics LLC, an AbbVie Company
$96
Otsuka America Pharmaceutical, Inc.
$94
Array BioPharma Inc.
$87
Boehringer Ingelheim Pharmaceuticals, Inc.
$66
AbbVie, Inc.
$65
Lilly USA, LLC
$54
Gilead Sciences, Inc.
$46
EISAI INC.
$41
EMD Serono, Inc.
$40
Bayer HealthCare Pharmaceuticals Inc.
$38
Janssen Biotech, Inc.
$38
Taiho Oncology, Inc.
$37
TESARO, Inc.
$28
Rigel Pharmaceuticals, Inc.
$18
PORTOLA PHARMACEUTICALS, INC.
$15
Teva Pharmaceuticals USA, Inc.
$11
Top 3 companies account for 55.2% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · Alecensa · Avastin · BENDEKA · BEVYXXA · Bavencio · Blincyto · Braftovi · CABOMETYX · CEREZYME · CHANTIX · CRESEMBA · CYRAMZA · Cabometyx · DARZALEX · ELITEK · EMPLICITI · Empaveli · FASLODEX · GAUCHER-DISEASE · GAZYVA · GILOTRIF · Halaven · Herceptin · IMBRUVICA · IMFINZI · Imbruvica · JADENU · JAKAFI · JYNARQUE · KEYTRUDA · KISQALI · Kyprolis · LARTRUVO · LIBTAYO · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · NINLARO · Neulasta · OPDIVO · ORGOVYX · Optune · PROMACTA · Perjeta · REBLOZYL · RYLAZE · Revlimid · SOLIRIS · SUTENT · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · Tavalisse · ULTOMIRIS · Ultomiris · VELCADE · VENCLEXTA · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Yescarta · ZEJULA · ZOLADEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (42%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $16,752 per 100 Medicare services performed
Looking for a hematology & oncology in Lubbock?
Compare hematology & oncologys in the Lubbock area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
5
Per 100K population
1.6
County median income
$63,367
Nearest hospital
UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Dcunha is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 18%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Dcunha experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Dcunha performed 109 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dcunha receive payments from pharmaceutical companies?
Yes. Dr. Dcunha received a total of $26,468 from 46 companies across 252 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dcunha's costs compare to other hematology & oncologys in Lubbock?
Dr. Dcunha's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dcunha) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →